Windows en Linux
Houdt de toets ctrl ingedrukt en draai het muiswiel omhoog of omlaag
Of houdt de toets ctrl ingedrukt en druk tegelijk op de toets + of -
Of ga rechtsboven naar instellingen en gebruik de instelling zoom
Mac
Houdt de toets command ingedrukt en druk op de toets + of -
Of ga rechtsboven naar instellingen en gebruik de instelling zoom.
Pharmacological boosting of azacitidine/venetoclax in acute myeloid leukemia
1 Cobicistat allowed an 8-fold reduction in venetoclax while optimizing exposure, demonstrating a cost-effective strategy for AML treatment. 2 Cobicistat
Integrative preclinical strategy for pharmacokinetic profiling and candidate selection of 3-hydroxypropanamidines: a promising antimalarial class
TKK130 was identified as the most favorable compound of the novel antimalarial 3-hydroxypropanamidines because of its encouraging pharmacokinetic profile, combined
Uncovering the ultra‐frail: A distinct subgroup in non‐transplant eligible newly diagnosed patients with multiple myeloma, with an inferior clinical outcome
Non-transplant eligible patients with newly diagnosed multiple myeloma (NTE-NDMM) who are categorized as frail according to the International Myeloma Working
Kinetics of Serum-Free Light Chain Removal by High-Cutoff Hemodialysis in Patients with Multiple Myeloma and Acute Renal Failure
<i>Background and objectives</i>: Cast nephropathy is the main cause of acute renal failure in patients with multiple myeloma. There are
Long-term progression-free survival benefit with ciltacabtagene autoleucel in standard-risk relapsed / refractory multiple myeloma
Abstract Introduction: The CARTITUDE-4 study (NCT04181827), which enrolled patients with lenalidomide-refractory multiple myeloma (MM) after 1–3 prior lines of therapy
- 1
- 2